Connection

Roberto Maroldi to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Roberto Maroldi has written about Antibodies, Monoclonal, Humanized.
Roberto Maroldi
Connection Strength
0.044
Antibodies, Monoclonal, Humanized
  1. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.